scholarly article | Q13442814 |
P50 | author | Elizabeth Barrett-Connor | Q37322423 |
Donna Kritz-Silverstein | Q37322562 | ||
P2093 | author name string | Alan S Maisel | |
Paul Clopton | |||
Gail A Laughlin | |||
Lori B Daniels | |||
Wei-Chung Chen | |||
P2860 | cites work | “Mini-mental state” | Q25938989 |
Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia | Q33441223 | ||
Cardiac index is associated with brain aging: the Framingham Heart Study | Q34090309 | ||
Plasma natriuretic peptide levels and the risk of cardiovascular events and death | Q34298401 | ||
Cognitive deficits in patients with heart failure: a review of the literature | Q35167337 | ||
Cognitive impairment in heart failure with Cheyne-Stokes respiration | Q35377564 | ||
Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI | Q36368924 | ||
Brain natriuretic peptide predicts mortality in the elderly | Q36841331 | ||
Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study | Q37036751 | ||
Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease | Q37097161 | ||
Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease | Q37356606 | ||
The potentially harmful medical consequences of untreated sleep-disordered breathing: the evidence supporting brain damage | Q37468039 | ||
Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels | Q39902483 | ||
Endothelial function and dysfunction in heart failure | Q42460322 | ||
Late-life dementias: does this unyielding global challenge require a broader view? | Q42907660 | ||
Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. | Q43615574 | ||
Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system | Q44178691 | ||
Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation | Q44195434 | ||
Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay | Q44668764 | ||
Hypertension and the brain: vulnerability of the prefrontal regions and executive functions | Q48116852 | ||
Elevated levels of brain natriuretic peptide as a predictor of impaired coronary endothelial function in patients with left ventricular remodeling | Q48410893 | ||
Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among obstructive sleep apnoea patients | Q48447902 | ||
Biochemical detection of left-ventricular systolic dysfunction | Q48562979 | ||
Differential cortical atrophy in subgroups of mild cognitive impairment. | Q48770359 | ||
Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment. | Q51024714 | ||
Cardiac dysfunction and cognition in older adults with heart failure. | Q51889848 | ||
Profile of cognitive impairment in chronic heart failure. | Q51900016 | ||
What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? | Q53617945 | ||
A High Plasma Concentration of TNF- Is Associated With Dementia in Centenarians | Q59326375 | ||
Neurocognitive functioning and improvement in quality of life following participation in cardiac rehabilitation | Q60619380 | ||
The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group | Q67748287 | ||
Natriuretic peptides | Q80396416 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 670.e1-8 | |
P577 | publication date | 2011-07-01 | |
P1433 | published in | American Journal of Medicine | Q2842959 |
P1476 | title | Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults | |
P478 | volume | 124 |
Q35034827 | Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study |
Q92024637 | Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis |
Q40347969 | Association Between Subclinical Cardiac Biomarkers and Clinically Manifest Cardiac Diseases With Cortical Cerebral Microinfarcts |
Q44120239 | B-type natriuretic peptide and severity of cognitive disorder |
Q38805023 | Cognitive decline in heart failure |
Q34954444 | Cognitive impairment in heart failure patients |
Q35573378 | Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients |
Q45305673 | Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain. |
Q48901180 | High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk |
Q34436072 | Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease |
Q36152775 | Markers of cardiac dysfunction in cognitive impairment and dementia |
Q38388347 | N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort |
Q55040636 | N-Terminal pro-Brain Natriuretic Peptide and Associations With Brain Magnetic Resonance Imaging (MRI) Features in Middle Age: The CARDIA Brain MRI Study. |
Q36005627 | N-terminal pro-brain natriuretic peptide and abnormal brain aging: The AGES-Reykjavik Study |
Q48709088 | N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk |
Q34248217 | NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus Study |
Q36290732 | Neurocognitive function and CNS integrity in adult survivors of childhood hodgkin lymphoma |
Q33848664 | Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study |
Q64243768 | SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients |
Q48206492 | The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population |
Q35700320 | The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors |
Q53489811 | [Methylphenidate in a patient with Alzheimer's disease : Increase in drive and cardiac performance]. |